Extracorporeal Filtration of Subarachnoid Hemorrhage Via Spinal Catheter

Status: Completed
Location: See all (4) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The objective of this feasibility study is to demonstrate the safety and feasibility of using an investigational extracorporeal system and catheter to filter hemorrhagic cerebrospinal fluid (CSF) post subarachnoid hemorrhage (SAH) treatment, and reintroduce the CSF via the same catheter.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: No
View:

• Age: 18 years or older

• Informed consent by the patient or his/her legally authorized representative

• Modified Fisher Grade 2, 3, or 4

• Hunt & Hess I-III

• First aneurysmal SAH that has been confirmed by Angio, CTA or MRA

• Patient is ≤ 48 hours post bleeding event

• World Federation of Neurosurgeons (WFNS) Grades I-IV and those Grade V patients who improve to Grade IV or less after ventriculostomy.

Locations
United States
Minnesota
University of Minnesota
Minneapolis
North Carolina
Duke University
Durham
Pennsylvania
Thomas Jefferson University
Philadelphia
Texas
Memorial Hermann
Houston
Time Frame
Start Date: March 23, 2017
Completion Date: August 31, 2018
Participants
Target number of participants: 15
Treatments
Experimental: Treatment Group
Related Therapeutic Areas
Sponsors
Leads: Minnetronix

This content was sourced from clinicaltrials.gov

Similar Clinical Trials